30개국의 체외진단(IVD) 시장(2025년)

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025

US $ 5,600 ￦ 7,946,000

Online Access (Single User License)

PDF 보고서를 1분이 열람(다운로드 불가)할 수 있는 라이선스입니다. 인쇄는 1회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,352,000

Online Access & PDF Download (Unlimited Users)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

이 보고서는 미국, 중국, 독일, 영국, 사우디아라비아, 인도, UAE, 프랑스, 베트남, 터키 등 주요 30개국의 체외진단(IVD) 시장을 포괄적으로 분석합니다. 상세한 시장 규모, 2029년 및 2030년 예측, 2025년까지의 분기별 업데이트를 통해 진화하는 세계 체외진단 시장에 대한 시의적절한 인사이트를 제공합니다.

주요 IVD 분야 상세 예측

목차

제1장 세계의 IVD 시장

• IVD 시장 수요와 성장
• 범위와 조사 방법
• 시장 세분화

제2장 미국의 IVD 시장

• 미국의 IVD 시장 개요
• 미국의 IVD 뉴스

제3장 독일의 IVD 시장

• 독일의 IVD 시장 개요
• 독일의 IVD 뉴스

제4장 중국

• 중국의 IVD 시장 개요
• 중국의 IVD 뉴스

제5장 일본의 IVD 시장

• 일본의 IVD 시장 개요
• 일본의 IVD 뉴스

제6장 프랑스

• 프랑스의 IVD 시장 개요
• 프랑스의 IVD 뉴스

제7장 영국

• 영국의 IVD 시장 개요
• 영국의 IVD 뉴스

제8장 이탈리아

• 이탈리아의 IVD 시장 개요
• 이탈리아의 IVD 뉴스

제9장 캐나다

• 캐나다의 IVD 시장 개요
• 캐나다의 IVD 뉴스

제10장 스페인

• 스페인의 IVD 시장 개요
• 스페인의 IVD 뉴스

제11장 호주

• 호주의 IVD 시장 개요
• 호주의 IVD 뉴스

제12장 브라질

• 브라질의 IVD 시장 개요

제13장 인도

• 인도의 IVD 시장 개요
• 인도의 IVD 뉴스

제14장 러시아

• 러시아의 IVD 시장 개요

제15장 네덜란드

• 네덜란드의 IVD 시장 개요
• 네덜란드의 IVD 뉴스

제16장 스위스

• 스위스의 IVD 시장 개요
• 스위스의 IVD 뉴스

제17장 폴란드

• 폴란드의 IVD 시장 개요

제18장 터키

• 터키의 IVD 시장 개요

제19장 멕시코

• 멕시코의 IVD 시장 개요

제20장 스웨덴

• 스웨덴의 IVD 시장 개요

제21장 벨기에

• 벨기에의 IVD 시장 개요

제22장 오스트리아

• 오스트리아의 IVD 시장 개요

제23장 사우디아라비아

• 사우디아라비아의 IVD 시장 개요

제24장 한국

• 한국의 IVD 시장 개요
• 한국의 IVD 뉴스

제25장 이집트

• 이집트의 IVD 시장 개요

제26장 루마니아

• 루마니아의 IVD 시장 개요

제27장 남아프리카공화국

• 남아프리카공화국의 IVD 시장 개요

제28장 인도네시아

• 인도네시아의 IVD 시장 개요

제29장 칠레

• 칠레의 IVD 시장 개요

제30장 아랍에미리트

• 아랍에미리트의 IVD 개요
• 아랍에미리트의 IVD 뉴스

제31장 베트남

• 베트남의 IVD 시장 개요

부록 : 30개국의 IVD 부문 전체

ksm

영문 목차

영문목차

Kalorama Information's "30-Country IVD Market Atlas, 2025" provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama's "30-Country IVD Market Atlas, 2025" consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report's quarterly updates via Kalorama's Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

TABLE OF CONTENTS

CHAPTER 1: WORLDWIDE IVD MARKET

• IVD MARKET DEMAND AND GROWTH
• SCOPE AND METHODOLOGY
• MARKET SEGMENTATION
  • Country Atlas Scope
    • Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2024
    • Table 1-2: Global IVD Market by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
    • Figure 1-1: Global IVD Market by Leading Countries, Estimated 2024 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
    • Figure 1-2: Global IVD Market by Leading Countries, Estimated 2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

CHAPTER 2: U.S. IVD MARKET

• UNITED STATES IVD MARKET OVERVIEW
  • Table 2-1: U.S. IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 2-1: U.S. IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 2-2: U.S. IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN THE UNITED STATES

CHAPTER 3: GERMANY IVD MARKET

• GERMANY IVD MARKET OVERVIEW
  • Table 3-1: Germany IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 3-1: Germany IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 3-2: Germany IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN GERMANY

CHAPTER 4: CHINA

• CHINA IVD MARKET OVERVIEW
  • Table 4-1: China IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 4-1: China IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 4-2: China IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN CHINA

CHAPTER 5: JAPAN IVD MARKET

• JAPAN IVD MARKET OVERVIEW
  • Table 5-1: Japan IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 5-1: Japan IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 5-2: Japan IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN JAPAN

CHAPTER 6: FRANCE

• FRANCE IVD MARKET OVERVIEW
  • Table 6-1: France IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 6-1: France IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 6-2: France IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN FRANCE

CHAPTER 7: UNITED KINGDOM

• UNITED KINGDOM IVD MARKET OVERVIEW
  • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 7-1: United Kingdom IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 7-2: United Kingdom IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN THE UNITED KINGDOM

CHAPTER 8: ITALY

• ITALY IVD MARKET OVERVIEW
  • Table 8-1: Italy IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 8-1: Italy IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 8-2: Italy IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN ITALY

CHAPTER 9: CANADA

• CANADA IVD MARKET OVERVIEW
  • Table 9-1: Canada IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 9-1: Canada IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 9-2: Canada IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN CANADA

CHAPTER 10: SPAIN

• SPAIN IVD MARKET OVERVIEW
  • Table 10-1: Spain IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 10-1: Spain IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 10-2: Spain IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN SPAIN

CHAPTER 11: AUSTRALIA

• AUSTRALIA IVD MARKET OVERVIEW
  • Table 11-1: Australia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 11-1: Australia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 11-2: Australia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN AUSTRALIA

CHAPTER 12: BRAZIL

• BRAZIL IVD MARKET OVERVIEW
  • Table 12-1: Brazil IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 12-1: Brazil IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 12-2: Brazil IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 13: INDIA

• INDIA IVD MARKET OVERVIEW
  • Table 13-1: India IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 13-1: India IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 13-2: India IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN INDIA

CHAPTER 14: RUSSIA

• RUSSIA IVD MARKET OVERVIEW
  • Table 14-1: Russia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 14-1: Russia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 14-2: Russia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 15: THE NETHERLANDS

• THE NETHERLANDS IVD MARKET OVERVIEW
  • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 15-1: The Netherlands IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 15-2: The Netherlands IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN THE NETHERLANDS

CHAPTER 16: SWITZERLAND

• SWITZERLAND IVD MARKET OVERVIEW
  • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 16-1: Switzerland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 16-2: Switzerland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN SWITZERLAND

CHAPTER 17: POLAND

• POLAND IVD MARKET OVERVIEW
  • Table 17-1: Poland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 17-1: Poland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 17-2: Poland IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 18: TURKEY

• TURKEY IVD MARKET OVERVIEW
  • Table 18-1: Turkey IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 18-1: Turkey IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 18-2: Turkey IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 19: MEXICO

• MEXICO IVD MARKET OVERVIEW
  • Table 19-1: Mexico IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 19-1: Mexico IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 19-2: Mexico IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 20: SWEDEN

• SWEDEN IVD MARKET OVERVIEW
  • Table 20-1: Sweden IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 20-1: Sweden IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 20-2: Sweden IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 21: BELGIUM

• BELGIUM IVD MARKET OVERVIEW
  • Table 21-1: Belgium IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 21-1: Belgium IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 21-2: Belgium IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 22: AUSTRIA

• AUSTRIA IVD MARKET OVERVIEW
  • Table 22-1: Austria IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 22-1: Austria IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 22-2: Austria IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 23: SAUDI ARABIA

• SAUDI ARABIA IVD MARKET OVERVIEW
  • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 23-2: Saudi Arabia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 24: SOUTH KOREA

• SOUTH KOREA IVD MARKET OVERVIEW
  • Table 24-1: South Korea IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 24-1: South Korea IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 24-2: South Korea IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN SOUTH KOREA

CHAPTER 25: EGYPT

• EGYPT IVD MARKET OVERVIEW
  • Table 25-1: Egypt IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 25-1: Egypt IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 25-2: Egypt IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 26: ROMANIA

• ROMANIA IVD MARKET OVERVIEW
  • Table 26-1: Romania IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 26-1: Romania IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 26-2: Romania IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 27: SOUTH AFRICA

• SOUTH AFRICA IVD MARKET OVERVIEW
  • Table 27-1: South Africa IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 27-1: South Africa IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 27-2: South Africa IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 28: INDONESIA

• INDONESIA IVD MARKET OVERVIEW
  • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 28-1: Indonesia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 28-2: Indonesia IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 29: CHILE

• CHILE IVD MARKET OVERVIEW
  • Table 29-1: Chile IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 29-1: Chile IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 29-2: Chile IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER 30: UNITED ARAB EMIRATES

• UNITED ARAB EMIRATES IVD OVERVIEW
  • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 30-2: United Arab Emirates IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• IVD NEWS IN THE UNITED ARAB EMIRATES

CHAPTER 31: VIETNAM

• VIETNAM IVD MARKET OVERVIEW
  • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 31-1: Vietnam IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 31-2: Vietnam IVD Market by Segment, Estimated 2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

APPENDIX: 30-COUNTRY IVD SEGMENT TOTALS

• Table A-1: Blood Bank Screening (Immunos), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-2: Coagulation PT/INR, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-3: Critical Care (core lab), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-4: General Chemistries, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-5: Hematology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-6: Histology, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-7: Immunoassays (Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-8: Immunoassays (Non-Micro), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-9: Microbiology (ID/AST), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-10: Molecular Bloodstream/HAI, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-11: Molecular HIV & Hepatitis, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-12: Molecular Respiratory, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-13: Molecular (Other), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-14: POC Critical Care , Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-15: POC Fecal Occult, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-16: POC Glucose (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-17: POC Infectious Disease (all), Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-18: POC Pregnancy & Fertility, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-19: Other IVD, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• Table A-20: Other POC, Global IVD Segment by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

관련자료